Alamar Biosciences, Inc. (California) (ALMR)
30.50
-0.14
(-0.46%)
USD |
NASDAQ |
Nov 18, 16:00
30.50
0.00 (0.00%)
After-Hours: 20:00
Alamar Biosciences Shareholders Equity (Quarterly) : 303.70M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 303.70M |
| June 30, 2026 | 312.86M |
| Date | Value |
|---|---|
| March 31, 2026 | -178.07M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Personalis, Inc. | 212.67M |
| 10X Genomics, Inc. | 838.04M |
| Champions Oncology, Inc. | 3.893M |
| Medpace Holdings, Inc. | 584.94M |
| Avantor, Inc. | 5.836B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 378.03M |
| Total Liabilities (Quarterly) | 74.32M |
| Debt to Equity Ratio | 0.1394 |
| Current Ratio | 9.488 |
| Net Debt Paydown Yield | -0.36% |